Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Disease Models, Animal

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atkins, HL; Brill, AB; Kubota, K; Meinken, GE; Sacker, DF; Som, P; Srivastava, SC1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Disease Models, Animal

ArticleYear
Comparative dual-tracer studies of carbon-14 tryptophan and iodine-131 HIPDM in animal models of pancreatic diseases.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1989, Volume: 30, Issue:11

    Topics: Animals; Autoradiography; Carbon Radioisotopes; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Iodine Radioisotopes; Iodobenzenes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Pancreatic Diseases; Protein Biosynthesis; Radionuclide Imaging; Tissue Distribution; Tryptophan; Whole-Body Counting

1989